Answers are grounded in this paper and cite their sources.
Cisplatin (CDDP)-induced nephrotoxicity is mediated via oxidative stress and may be alleviated using antioxidant activity. Although megadose of vitamin C may cause oxalate nephropathy and apoptosis, the antioxidant effect of vitamin C may be beneficial when given along with CDDP. The objective of this study was to investigate the renoprotective effects of megadose vitamin C on rats receiving CDDP. Rats were divided into 4 groups: group 1, control rats (CONT); group 2, vitamin C-treated rats (VIT C); group 3, CDDP-treated rats (CDDP) and group 4, CDDP + vitamin C-treated rats (CDDP + VIT C). Vitamin C (1000 mg/kg) was given intravenously to the VIT C and CDDP + VIT C groups while CDDP (6 mg/kg) was injected intraperitoneally into the CDDP and CDDP + VIT C groups. Renal function, oxidative stress, apoptosis and histopathology were investigated. At 5 days after injection, CDDP caused renal impairment as shown by significant increases in plasma concentrations of creatinine (PCr), urea nitrogen (PUN), urinary excretion of electrolytes (Na+, K+ and Cl-) and protein (P<0.05). Plasma malondialdehyde (P-MDA) and urinary MDA and creatinine ratio (U-MDA/Cr) were also increased (P<0.05). Kidney PCR products of antiapoptosis/proapoptosis (Bcl-2/Bax) were reduced by CDDP while histopathologic results showed severe massive tubular necrosis. Giving megadose vitamin C along with CDDP showed improvement on all renal function parameters and oxidative stress parameters except proteinuria. The vitamin C caused improvement on tubular cell lesions, but did not alter the Bcl-2/Bax level. It is concluded that megadose vitamin C can provide protection against CDDP-induced kidney injury by antioxidant activity.
No takes yet. Share an insight, caveat, or question.
Sithanukul et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: